Research analyst, medium-term horizon, biotech, small-cap

OxySure Systems - An Undiscovered Medical Play With Improving Fundamentals

In May 2013, OxySure Systems, Inc. (OTCPK:OXYS) reported financial results for the first quarter ended March 31, 2013. Total revenues in the quarter were $240K, an increase of a whopping 762% over the same period in 2012 and over twice our forecast of $95K. Revenues were driven by a combination of new customer wins, repeat business with existing customers, and signing new distribution partners both in the U.S. and internationally. International license and distribution payments in the quarter totaled $125k, far greater than we expected. We expect the momentum to continue in 2013 with respect to gaining approvals, and signing new partnerships and distribution agreements.

- For example, in March 2013, the company signed a deal with Aero...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details